Gender-Affirming Hormone Therapy and Risk of Inflammatory Bowel Disease Flare in Transgender and Gender Diverse Adults.
Saved in:
| Title: | Gender-Affirming Hormone Therapy and Risk of Inflammatory Bowel Disease Flare in Transgender and Gender Diverse Adults. |
|---|---|
| Authors: | Bennett A; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Field J; University of California San Francisco, San Francisco, California, USA., Newman KL; University of Michigan, Ann Arbor, Michigan, USA., Click B; University of Colorado, Aurora, Colorado, USA., Pothula S; University of Colorado, Aurora, Colorado, USA., Horst S; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Davison J; Mayo Clinic Rochester, Rochester, Minnesota, USA ., Lin A; University of Michigan, Ann Arbor, Michigan, USA., Chedid V; Mayo Clinic Rochester, Rochester, Minnesota, USA . |
| Source: | The American journal of gastroenterology [Am J Gastroenterol] 2026 Feb 01; Vol. 121 (2), pp. 404-409. Date of Electronic Publication: 2025 May 16. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 0421030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1572-0241 (Electronic) Linking ISSN: 00029270 NLM ISO Abbreviation: Am J Gastroenterol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1572-0241 |
|---|---|
| DOI: | 10.14309/ajg.0000000000003543 |
